July 21, 2018
Article
An Extraordinary Healer essay honoring MARCUS GASAWAY, B.S., RN, OCN [TEXAS ONCOLOGY-AUSTIN MIDTOWN, AUSTIN, TEXAS]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC